The performance of companies tied to flagship drugs like Viagra presents a challenging investment landscape . While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the patent expiration in key markets has introduced considerable volatility. Investors are now assessing the consequences of ri